Blood Collection Tubes Market - Forecast(2022 - 2027)

Blood Collection Tubes Market size is estimated to reach $2.47 billion by 2027, growing at a CAGR of 5.1% during the forecast period 2022-2027. Blood collection tubes are sterile glass or plastic tubes with a vacuum within expediting the draw of a predetermined volume of liquid. Most typically utilized to accumulate blood samples in venipuncture, they are planned for the accumulation, transfer, and processing of skin puncture blood. The suggested range of heparin in evacuated tubes is 10 to 30 USP units of heparin/mL of blood. Tubes including heparin need to be inverted 8 to 10 times consequent to accumulation to guarantee comprehensive mixing of the additive with the blood and, thus, complete anticoagulation of the sample. BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin. Samples accumulated in these tubes are utilized for plasma determinations in chemistry. EDTA serves as an anticoagulant in a vacutainer blood collection tube. Therefore, it averts clot formation. Ethylene Diamine Tetra Acetic Acid (EDTA) tube has a lavender cap as per International Standard and a red cap as per European Standard. It is the anticoagulant utilized for most hematology processes like recognizing and counting blood cells and blood typing. The EDTA blood sample can effortlessly last for at least 4 hours at room temperature and for a few days within the freezer. Also, it assists to conserve the morphology of the blood cells. EDTA tubes are utilized for most hematology treatments. The application of vinyl plastic blood bags and tubing in transfusion medicine is beneficial in the accumulation, processing, repository, and distribution of blood constituents. Serum-separating tubes, also termed serum separating tubes or SSTs, are utilized in medical clinical chemistry tests needing blood serum.

The surging count of surgeries requiring the application of heparin tubes owing to different conditions and accidents is set to drive the Blood Collection Tubes Market. The growing health awareness in conjunction with the surging application of blood samples in the diagnosis and need of blood constituents in the treatment of numerous ailments is set to propel the growth of the Blood Collection Tubes Market during the forecast period 2022-2027. This represents the Blood Collection Tubes Industry Outlook.

Blood Collection Tubes Market Report Coverage

The report: “Blood Collection Tubes Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the  Blood Collection Tubes Market.

By Product Type: Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Rapid Serum Tubes, Others.
By Material Type: Plastic, Glass.
By End Use: Hospitals And Clinics, R&D Centres, Diagnostic Centres, Others.
By Geography: North America (the U.S, Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

• Geographically, North America Blood Collection Tubes Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the surging pervasiveness of accidents which may require the application of blood bags and incessant ailments in the North American region.
• Blood Collection Tubes Market growth is being driven by the expanding population of the elderly, the soaring application of serum separating tubes in medical clinical chemistry tests needing blood serum, and the increasing predominance of incessant ailments. However, the hazard of obtaining infections owing to unhygienic blood transfusion is one of the major factors hampering the growth of the Blood Collection Tubes Market. 
• Blood Collection Tubes Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Blood Collection Tubes Market report. 

Blood Collection Tubes Market Segment Analysis – By Product Type:

The Blood Collection Tubes Market based on product type can be further segmented into Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Rapid Serum Tubes and Others. The EDTA Tubes Segment held the largest market share in 2021. This growth is owing to the soaring application of EDTA Tubes for nearly all hematology processes like ablation therapy and blood transfusions. EDTA Tubes may include K2 EDTA or K3 EDTA. The raised count of accidents and blood transfusions at the time of surgeries and cancer therapy are further propelling the growth of the EDTA Tubes segment.

Furthermore, the Serum Separating Tubes segment is estimated to grow with the fastest CAGR of 5.9% during the forecast period 2022-2027 owing to the soaring application of serum separating tubes for serum separation which is utilized for distinct kinds of diagnosis.

Blood Collection Tubes Market Segment Analysis – By End Use:

The Blood Collection Tubes Market based on end-use can be further segmented into Hospitals And Clinics, R&D Centres, Diagnostic Centres, and Others. The Hospitals And Clinics Segment held the largest market share in 2021. This growth is owing to the soaring diagnosis and treatments worldwide. Different kinds of blood collection tubes may be utilized in hospitals and clinics including heparin tubes for surgeries. The surging application of vacutainer tubes owing to their security, effortless application, and reduced risk of hemolysis is further propelling the growth of this segment.

Furthermore, the Diagnostic Centres segment is estimated to grow with the fastest CAGR of 6.1% during the forecast period 2022-2027 owing to the surging population of the elderly who are susceptible to different ailments and the increasing predominance of ailments like red blood cell disorders needing periodic blood transfusion resulting in the application of EDTA tubes.

Blood Collection Tubes Market Segment Analysis – By Geography:

The Blood Collection Tubes Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Blood Collection Tubes Market) held the largest share with 47% of the overall market in 2021. The growth of this region is owing to the soaring presence of key players like Becton Dickinson & Company in Franklin Lakes, New Jersey, the U.S.  in the region. The favorable healthcare policies and the surging count of patients in the U.S. requiring the application of EDTA tubes for blood collection are further driving the growth of the Blood Collection Tubes Market in this region. The existence of well-developed healthcare facilities is further propelling the growth of the Blood Collection Tubes Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like a boost in government backing and the surging progress in blood collection technology in the Asia-Pacific region. The expanding population of the elderly and the increasing need for blood transfusion for the treatment of distinct hematological ailments requiring the application of EDTA tubes are further fuelling the progress of the Blood Collection Tubes Market in the Asia-Pacific region.

Blood Collection Tubes Market Drivers

Surging Applications Of EDTA Tubes Are Projected To Drive The Growth Of Blood Collection Tubes Market:

EDTA denotes Ethylenediaminetetraacetic acid, which is the anticoagulant utilized for nearly all hematology processes like recognizing and counting blood cells and blood typing. Tubes may include K2 EDTA or K3 EDTA. K2 EDTA is an anticoagulant utilized in blood collection procedures. K3 EDTA is a substitute anticoagulant for K2 EDTA. Consequent to treatment by EDTA, the plasma may be utilized to assess nearly all proteins. Furthermore, it expedites the stocking of genetic material by way of EDTA buffy coats, which is the interface between the red cells and the plasma subsequent to centrifugation. Historically, EDTA has been endorsed as the anticoagulant of selection for hematological testing owing to its ability to permit the most excellent conservation of cellular constituents and morphology of blood cells. The exceptional extension in laboratory test volume and complexity over current decades has intensified the possible spectrum of uses for this anticoagulant, which can be utilized to balance blood for an assortment of conventional and creative tests. The surging applications of EDTA Tubes are therefore fuelling the growth of the Blood Collection Tubes Market during the forecast period 2022-2027.

Soaring Applications Of Serum Separating Tubes Are Expected To Boost The Demand Of Blood Collection Tubes Market:

Serum separating tubes, also termed serum separator tubes or SSTs are utilized in medical clinical chemistry tests needing blood serum. They include a special gel that segregates blood cells from serum and particles to bring about blood to clot fast. The blood sample can then be centrifuged, permitting the clear serum to be eliminated for testing. Serum collecting tubes or serum separator tubes are convenient uses of the evacuated blood collection system. These tubes have acquired extensive adoption owing to the benefit of the barrier gel that expedites accelerated segregation of serum from cellular components of blood and therefore minimizes hemolysis. It can minimize the pre-analytical turnaround time without considerable clinical effect on normal clinical chemistry tests. The soaring applications of serum separating tubes are driving the growth of the Blood Collection Tubes Market during the forecast period 2022-2027.

Blood Collection Tubes Market – Challenges

Disadvantages Of Blood Collection Systems Are Hampering The Growth Of The Blood Collection Tubes Market:

Becton, Dickinson, and Company (BD) have developed BD Vacutainer® Tubes, Needles, and Holders which are utilized in conjunction as a system for the accumulation of venous blood. BD Vacutainer® Tubes are utilized to transfer and process blood for testing serum, plasma, or whole blood in the clinical laboratory. BD Vacutainer® Tubes are evacuated tubes with color-coded traditional stoppers or BD Hemogard™ Closures. The amount of blood drawn changes with altitude, ambient temperature, barometric pressure, tube age, venous pressure, and filling method. Tubes withdraw volume tinier than the seeming proportions designated (partial draw tubes), may fill more gradually than tubes of the identical size with greater draw volume. For those tubes exposed to centrifugation to produce plasma or serum for testing, standard processing conditions do not essentially fully sediment all cells, whether or not barrier gel is existing. Correspondingly, cell-based metabolism and an organic deterioration ex vivo influence serum/plasma analyte concentrations/activities beyond acellular alterations. It is advocated that testing for glucose, uric acid, and lactate dehydrogenase (LD) be carried out as quickly after collection and separation as possible. Owing to natural deterioration, deferment in segregation of the serum or plasma from the cellular mass or in testing after segregation will lead to erroneous outcomes for those analytes. These issues are thus hampering the growth of the Blood Collection Tubes Market.

Blood Collection Tubes Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Blood Collection Tubes Market. Key companies of this market are:

1. Sunphoria Co. Ltd.
2. Narang Medical Limited
3. CML Biotech
4. Bio – X
5. Labtech Disposables
6. Hebei Xinle Sci &Tech Co., Ltd.
7. Greiner Bio-One International
8. Becton Dickinson & Company
9. QIAGEN N.V
10. AdvaCare Pharma

Recent Development

• In November 2021, BD (Becton, Dickinson, and Company) declared the introduction of the BD UltraSafe Plus™ 2.25 mL Passive Needle Guard for application by pharmaceutical firms in medication-tool integration products.  When integrated with a Glass Prefillable Syringe, the BD UltraSafe Plus™ 2.25 mL system permits the subcutaneous transfer of biologic solutions of distinct fill volumes up to 2 mL and viscosities up to 30 cP.  BD UltraSafe Plus™ 2.25 mL is the most-recent solution to be commercially delivered into BD’s portfolio of medication delivery systems for integration products and is planned to satisfy the requirements of healthcare providers, patients, and caregivers in carrying out manual injections of biologic solutions.

• In November 2021, QIAGEN declared the inclusion of StableScript™ to the OEM (Original Equipment Manufacturer) portfolio. The adaptable reverse transcriptase is planned for application in one-step RT-qPCR and long-range RT-PCR and is accessible to order in large amounts. The launch of reverse transcriptases has permitted polymerase chain reaction (PCR) to be administered to RNA and the formulation of cDNA libraries from mRNA.

• In May 2021, Greiner Bio-One International GmbH has currently issued an extensive assortment of cell culture flasks. Issued under the brand name of CELLSTAR, the flasks have been planned particularly to provide for exacting laboratory requirements. Every flask has been formed utilizing polystyrene of excellent quality, which boosts the longevity and guarantees durability.

Related Reports-